Camber Launches Generic Sustiva®
Piscataway, NJ, May 2, 2018– Camber Pharmaceuticals is pleased to announce the addition of Efavirenz Tablets to our growing portfolio of products.
Efavirenz tablets are the generic version of Sustiva®. Sustiva is used to treat HIV.
Efavirenz tablets are available in 600mg 30ct bottle.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability.
If you would like more information about this topic, please contact Kirk Hessels at 732.529.0430 or email at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection